Ledger.Open graph →
SEC Form D · Amendment · filed March 17, 2017

Akeso Biomedical, Inc

Offering
$5.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Other
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Anthony W. Sinskey · Boston, MADirectorGreg C. Lee · Fayetteville, ARDirectorRobert C. Goforth · Fayetteville, ARDirectorMark C. Kidd · Fayetteville, ARExecSimon W. Williams · Waltham, MAExec · DirectorBernard W. Prusaczyk · Waltham, MADirectorScott W. Roth · Waltham, MADirectorLinzy O. Scott · Atlanta, GAExecRichard A. Martin · Lubbock, TXExec · DirectorTimothy J. Carver · Fort Lauderdale, FLDirectorRajiv N. Jain · Fort Lauderdale, FLDirectorJames L. Hegyi · Darien, CTDirectorDavid R. Webb · VANCOUVER, British Columbia, CanadaDirectorErik Hauck · Lexington, KYExecMatthew S. Kupersmith · Darien, CTDirectorHeidi Kalenuik · VANCOUVER, British Columbia, CanadaDirectorMichael K. Schilling · Nikiski, AKExec · DirectorRoger A. D'Orazio, Iii · Chicago, ILDirectorJohn Broucek Iv · Chicago, ILDirectorScott W. Roth · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗